Robust Health Limited 07863150 false 2022-12-01 2023-11-30 2023-11-30 The principal activity of the company is medical practice services. Digita Accounts Production Advanced 6.30.9574.0 true true 07863150 2022-12-01 2023-11-30 07863150 2023-11-30 07863150 bus:Director1 1 2023-11-30 07863150 bus:OrdinaryShareClass1 2023-11-30 07863150 bus:OrdinaryShareClass2 2023-11-30 07863150 bus:OrdinaryShareClass3 2023-11-30 07863150 bus:OrdinaryShareClass4 2023-11-30 07863150 core:RetainedEarningsAccumulatedLosses 2023-11-30 07863150 core:ShareCapital 2023-11-30 07863150 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:CurrentFinancialInstruments 2023-11-30 07863150 core:CurrentFinancialInstruments 2023-11-30 07863150 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 07863150 core:FurnitureFittingsToolsEquipment 2023-11-30 07863150 bus:SmallEntities 2022-12-01 2023-11-30 07863150 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 07863150 bus:FilletedAccounts 2022-12-01 2023-11-30 07863150 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 07863150 bus:RegisteredOffice 2022-12-01 2023-11-30 07863150 bus:Director1 2022-12-01 2023-11-30 07863150 bus:Director1 1 2022-12-01 2023-11-30 07863150 bus:Director2 2022-12-01 2023-11-30 07863150 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 07863150 bus:OrdinaryShareClass2 2022-12-01 2023-11-30 07863150 bus:OrdinaryShareClass3 2022-12-01 2023-11-30 07863150 bus:OrdinaryShareClass4 2022-12-01 2023-11-30 07863150 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 07863150 bus:Agent1 2022-12-01 2023-11-30 07863150 core:FurnitureFittingsToolsEquipment 2022-12-01 2023-11-30 07863150 core:OfficeEquipment 2022-12-01 2023-11-30 07863150 countries:England 2022-12-01 2023-11-30 07863150 2022-11-30 07863150 bus:Director1 1 2022-11-30 07863150 core:FurnitureFittingsToolsEquipment 2022-11-30 07863150 2021-12-01 2022-11-30 07863150 2022-11-30 07863150 bus:Director1 1 2022-11-30 07863150 bus:OrdinaryShareClass1 2022-11-30 07863150 bus:OrdinaryShareClass2 2022-11-30 07863150 bus:OrdinaryShareClass3 2022-11-30 07863150 bus:OrdinaryShareClass4 2022-11-30 07863150 core:RetainedEarningsAccumulatedLosses 2022-11-30 07863150 core:ShareCapital 2022-11-30 07863150 core:CurrentFinancialInstruments 2022-11-30 07863150 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 07863150 core:FurnitureFittingsToolsEquipment 2022-11-30 07863150 bus:Director1 1 2021-12-01 2022-11-30 07863150 bus:Director1 1 2021-11-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07863150

Robust Health Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 November 2023

 

Robust Health Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 10

 

Robust Health Limited

Company Information

Directors

Dr D Brinkmann

Mrs S Brinkmann

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Chartered Accountants
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Robust Health Limited
for the Year Ended 30 November 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Robust Health Limited for the year ended 30 November 2023 as set out on pages 3 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Robust Health Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Robust Health Limited and state those matters that we have agreed to state to the Board of Directors of Robust Health Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Robust Health Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Robust Health Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Robust Health Limited. You consider that Robust Health Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Robust Health Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Chartered Accountants
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

29 August 2024

 

Robust Health Limited

(Registration number: 07863150)
Balance Sheet as at 30 November 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

6,303

7,523

Current assets

 

Debtors

6

38,911

48,106

Other financial assets

5

138,100

60,000

Cash at bank and in hand

 

35,765

60,264

 

212,776

168,370

Creditors: Amounts falling due within one year

7

(24,732)

(15,971)

Net current assets

 

188,044

152,399

Total assets less current liabilities

 

194,347

159,922

Provisions for liabilities

(1,576)

(1,885)

Net assets

 

192,771

158,037

Capital and reserves

 

Called up share capital

8

320

330

Retained earnings

192,451

157,707

Shareholders' funds

 

192,771

158,037

 

Robust Health Limited

(Registration number: 07863150)
Balance Sheet as at 30 November 2023

For the financial year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 29 August 2024 and signed on its behalf by:
 

.........................................
Dr D Brinkmann
Director

.........................................
Mrs S Brinkmann
Director

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

These financial statements were authorised for issue by the Board on 29 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20%- written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2022 - 4).

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 December 2022

19,883

19,883

Additions

357

357

At 30 November 2023

20,240

20,240

Depreciation

At 1 December 2022

12,362

12,362

Charge for the year

1,575

1,575

At 30 November 2023

13,937

13,937

Carrying amount

At 30 November 2023

6,303

6,303

At 30 November 2022

7,523

7,523

5

Other financial assets (current and non-current)

Financial assets at fair value through profit and loss
£

Total
£

Current financial assets

Cost or valuation

At 1 December 2022

60,000

60,000

Additions

50,100

50,100

Transfers

28,000

28,000

At 30 November 2023

138,100

138,100

Impairment

Carrying amount

At 30 November 2023

138,100

138,100

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

6

Debtors

Current

2023
£

2022
£

Trade debtors

13,798

22,124

Other debtors

25,113

25,982

 

38,911

48,106

7

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

23,146

14,385

Accruals and deferred income

1,586

1,586

24,732

15,971

 

Robust Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

8

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary shares of £1 each

200

200

200

200

Ordinary A shares of £1 each

100

100

100

100

Ordinary B shares of £1 each

10

10

10

10

Ordinary C shares of £1 each

10

10

10

10

320

320

320

320

9

Related party transactions

Transactions with directors

2023

At 1 December 2022
£

Other payments made to company by director
£

At 30 November 2023
£

Dr D Brinkmann

Directors loan account which is undated, unsecured, interest free and repayable on demand

25,983

(868)

25,115

2022

At 1 December 2021
£

Other payments made to company by director
£

At 30 November 2022
£

Dr D Brinkmann

Directors loan account which is undated, unsecured, interest free and repayable on demand

36,004

(10,021)

25,983